IL6 and Glucose intolerance: Additionally, the knockout of tissue inhibitor of metalloproteinase 3 (Timp3) triggers liver steatosis and glucose intolerance due to induced dysbiosis and systemic inflammation via interleukin 6 (IL-6) signaling, with antibiotic treatment ameliorating these effects [40].